Siegel Todd E
Pres., CEO, COB at MTS MEDICATION TECHNOLOGIES, INC /DE/
- Sold, on record
- $1.4M
- Dollars the filings state
- Form 4 sales
- 4
- Latest Dec 22, 2009
- Form 144 notices
- 0
- Proposed sales
- Quarters with a sale
- 0 of the last 8
- No sale in two years
- Companies
- 1
- Filed as an executive or holder
Companies
- MTS MEDICATION TECHNOLOGIES, INC /DE/Pres., CEO, COB
Sales by reason
0
Routine
2
Plan not stated
0
No plan
2
Unusual
Form 4 sales per year, every sale on record.
Timeline
- Dec 22, 2009Unusual
MTS MEDICATION TECHNOLOGIES, INC /DE/
Sold 62.3% of their holdings
1M shares
- Nov 13, 2007Unusual
MTS MEDICATION TECHNOLOGIES, INC /DE/
Sold 50.6% of their holdings
$800k60,000 shares at $13.34
- Feb 23, 2007Plan not stated
MTS MEDICATION TECHNOLOGIES, INC /DE/
Sold 2.4% of their holdings
$417k39,590 shares at $10.54
- Feb 21, 2007Plan not stated
MTS MEDICATION TECHNOLOGIES, INC /DE/
Sold 1.2% of their holdings
$217k20,410 shares at $10.61
4 of 4
Every transaction
| Traded | Filed | Stock | Role | What | Amount | Price | Value | Held after | Source |
|---|---|---|---|---|---|---|---|---|---|
| Jun 1, 2026 | Jun 3, 2026 | OMEX | Director | Exercised or settledRestricted Stock Unit (RSU) | 20,000 | 0 | SEC | ||
| Jun 1, 2026 | Jun 3, 2026 | OMEX | Director | Exercised options | 20,000 | 166,377 | SEC | ||
| May 7, 2026 | May 11, 2026 | SGC | Director | Awarded | 9,583 | 75,607 | SEC | ||
| Apr 20, 2026 | Apr 22, 2026 | OMEX | Director | Awarded | 31,475 | 146,377 | SEC | ||
| Feb 6, 2026 | Feb 10, 2026 | OMEX | Director | Awarded | 7,937 | 114,902 | SEC | ||
| Jan 6, 2026 | Jan 8, 2026 | OMEX | Director | Awarded | 7,653 | 106,965 | SEC | ||
| Dec 5, 2025 | Dec 9, 2025 | OMEX | Director | Awarded | 7,282 | 99,312 | SEC | ||
| Dec 2, 2025 | Dec 4, 2025 | OMEX | Director | AwardedRestricted Stock Unit (RSU) | 50,000 | 30,000 | SEC | ||
| Nov 6, 2025 | Nov 10, 2025 | OMEX | Director | Awarded | 7,042 | 92,030 | SEC | ||
| Jul 1, 2025 | Jul 2, 2025 | SGC | Director | Awarded | 8,845 | 66,024 | SEC | ||
| Apr 14, 2025 | Apr 15, 2025 | OMEX | Director | Awarded | 28,083 | 84,988 | SEC | ||
| Nov 14, 2024 | Nov 18, 2024 | OMEX | Director | AwardedStock Option (Right to Buy) | 30,000 | 30,000 | SEC | ||
| Oct 23, 2024 | Nov 13, 2024 | OMEX | Director | Awarded | 13,954 | 56,905 | SEC | ||
| May 9, 2024 | May 10, 2024 | SGC | Director | AwardedNQ Stock Options | 2,750 | $19.91 | $55k | 2,750 | SEC |
| May 9, 2024 | May 10, 2024 | SGC | Director | Awarded | 3,766 | 57,719 | SEC | ||
| Apr 8, 2024 | Apr 10, 2024 | OMEX | Director | Awarded | 2,953 | 42,951 | SEC | ||
| Jan 29, 2024 | Jan 31, 2024 | OMEX | Director | AwardedStock Option (Right to Buy) | 30,000 | 30,000 | SEC | ||
| Nov 30, 2023 | Dec 4, 2023 | OMEX | Director | Awarded | 3,160 | 39,998 | SEC | ||
| Nov 8, 2023 | Nov 9, 2023 | SGC | Director | Awarded | 7,537 | 53,413 | SEC | ||
| Jun 9, 2023 | Jun 13, 2023 | OMEX | Director | Awarded | 5,311 | 36,838 | SEC | ||
| May 24, 2023 | May 26, 2023 | OMEX | Director | AwardedStock Option(Right to Buy) | 6,541 | 6,541 | SEC | ||
| May 12, 2023 | May 16, 2023 | SGC | Director | AwardedNQ Stock Options | 2,750 | $8.33 | $23k | 2,750 | SEC |
| Jan 17, 2023 | Jan 19, 2023 | OMEX | Director | Awarded | 10,245 | 31,527 | SEC | ||
| Nov 28, 2022 | Nov 29, 2022 | SGC | Director | Bought | 5,000 | $10.50 | $53k | 45,876 | SEC |
| Nov 4, 2022 | Nov 7, 2022 | SGC | Director | Awarded | 6,909 | 40,876 | SEC | ||
| Sep 30, 2022 | Oct 4, 2022 | OMEX | Director | Awarded | 4,435 | 21,282 | SEC | ||
| Jun 30, 2022 | Jul 5, 2022 | OMEX | Director | Awarded | 3,299 | 16,847 | SEC | ||
| May 13, 2022 | May 16, 2022 | SGC | Director | AwardedNQ Stock Options | 2,750 | $16.18 | $44k | 2,750 | SEC |
| Mar 31, 2022 | Apr 4, 2022 | OMEX | Director | Awarded | 2,365 | 13,548 | SEC | ||
| Jan 19, 2022 | Jan 21, 2022 | OMEX | Director | Awarded | 7,933 | 11,183 | SEC | ||
| Nov 11, 2021 | Nov 15, 2021 | SGC | Director | Awarded | 2,733 | 33,967 | SEC | ||
| May 14, 2021 | May 18, 2021 | SGC | Director | AwardedNQ Stock Options | 2,750 | $26.13 | $72k | 2,750 | SEC |
| Nov 6, 2020 | Nov 10, 2020 | SGC | Director | Awarded | 3,364 | 31,178 | SEC | ||
| May 12, 2020 | May 13, 2020 | SGC | Director | AwardedNQ Stock Options | 5,425 | $8.48 | $46k | 2,675 | SEC |
| Nov 1, 2019 | Nov 5, 2019 | SGC | Director | Awarded | 3,943 | 27,814 | SEC | ||
| May 3, 2019 | May 7, 2019 | SGC | Director | AwardedNQ Stock Options | 2,750 | $16.84 | $46k | 2,750 | SEC |
| Nov 2, 2018 | Nov 6, 2018 | SGC | Director | Awarded | 3,064 | 23,871 | SEC | ||
| May 3, 2018 | May 7, 2018 | SGC | Director | AwardedNQ Stock Options | 2,750 | $24.28 | $67k | 2,750 | SEC |
| Nov 1, 2017 | Nov 2, 2017 | SGC | Director | Awarded | 2,138 | 20,807 | SEC | ||
| May 5, 2017 | May 15, 2017 | SGC | Director | AwardedNQ Stock Options | 2,750 | $18.05 | $50k | 2,750 | SEC |
| Nov 4, 2016 | Nov 7, 2016 | SGC | Director | Awarded | 2,446 | $16.35 | $40k | 18,669 | SEC |
| May 6, 2016 | May 9, 2016 | SGC | Director | AwardedNQ Stock Options | 2,750 | $18.55 | $51k | 2,750 | SEC |
| Nov 6, 2015 | Nov 10, 2015 | SGC | Director | Awarded | 1,819 | $17.59 | $32k | 16,223 | SEC |
| Aug 31, 2015 | Sep 1, 2015 | SGC | Director | Bought | 2,900 | $17.14 | $50k | 14,404 | SEC |
| May 1, 2015 | May 4, 2015 | SGC | Director | AwardedNQ Stock Options | 2,750 | $16.78 | $46k | 2,750 | SEC |
| Nov 7, 2014 | Nov 10, 2014 | SGC | Director | Awarded | 752 | 5,752 | SEC | ||
| May 12, 2014 | May 14, 2014 | SGC | Director | Bought | 5,000 | $16.14 | $81k | 5,000 | SEC |
| May 2, 2014 | May 5, 2014 | SGC | Director | AwardedCommon Shares | 3,500 | $15.91 | $56k | 3,500 | SEC |
| Dec 22, 2009 | Dec 22, 2009 | MTS MEDICATION TECHNOLOGIES, INC /DE/ | Pres., CEO, COB | Sold | 1M | 606,125 | SEC | ||
| Dec 22, 2009 | Dec 22, 2009 | MTS MEDICATION TECHNOLOGIES, INC /DE/ | Pres., CEO, COB | Returned to the companyOptions (right to buy) | 56,777 | 0 | SEC |
Page 1
Sales and notices (4)
| Source | |||||||||
|---|---|---|---|---|---|---|---|---|---|
| Dec 22, 2009 | Dec 22, 2009 | MTS MEDICATION TECHNOLOGIES, INC /DE/ | Pres., CEO, COB | Form 4 sale | 1M | 62.3% | Unusual | SEC | |
| Nov 13, 2007 | Nov 15, 2007 | MTS MEDICATION TECHNOLOGIES, INC /DE/ | Pres. CEO COB | Form 4 sale | 60,000 | $800k | 50.6% | Unusual | SEC |
| Feb 23, 2007 | Feb 26, 2007 | MTS MEDICATION TECHNOLOGIES, INC /DE/ | Pres. CEO, COB | Form 4 sale | 39,590 | $417k | 2.4% | Plan not stated | SEC |
| Feb 21, 2007 | Feb 22, 2007 | MTS MEDICATION TECHNOLOGIES, INC /DE/ | Pres. CEO, COB | Form 4 sale | 20,410 | $217k | 1.2% | Plan not stated | SEC |